Clinical trial Recruiting at 1 site Interventional Ages 35 and up Women only

How short aerobic workouts affect tumor cells in breast cancer survivors

Official title: Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity (TCReX) No: RSU/LSPA-PA-2024/1-0004 is Financed by the Investment of the European Union Recovery and Resilience Facility and the State Budget Within the Project "RSU Internal and RSU With LASE External Consolidation" No. 5.2.1.1.i.0/2/24/I/CFLA/005.

Run by Riga Stradins University · NCT07439458 · Data updated 2026-11-12

This will test whether a single session of moderate or high intensity aerobic exercise changes circulating myokines and tumor cell responses in premenopausal women who survived stage II–III triple‑negative breast cancer compared with matched healthy women.

More Breast Cancer Survivors trials

Quick facts

Study typeInterventional
Ages35 Years and up
SexWomen only
Enrollment40 (estimated)
SponsorRiga Stradins University
Academic / other
Drugs / interventionschemotherapy, immunotherapy, radiation
Locations1 site (Riga, Dzirciema Street 16)
StatusRecruiting
StartedApril 1, 2024
Main results expectedMarch 31, 2026
Study endsSeptember 30, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07439458 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are premenopausal women with stage II–III triple‑negative breast cancer who are 3–9 months post‑surgery/chemotherapy/radiation/immunotherapy and have cardiologist clearance including echocardiography.

Probably not a fit

Women who are pregnant, have autoimmune, endocrine, or cardiovascular diseases, have another cancer diagnosis, or are not medically cleared for exercise are excluded and unlikely to gain from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional protocol compares the immediate biological effects of one session of moderate‑intensity versus high‑intensity continuous aerobic exercise on blood‑borne factors and tumor cell behavior. Premenopausal women who survived stage II–III triple‑negative breast cancer (3–9 months after completing treatment) and matched healthy control women will undergo cardiologist‑cleared exercise testing and supervised exercise sessions. Blood samples collected before and after exercise will be analyzed for myokine responses and applied to breast cancer cell lines to measure changes in tumor cell viability and signaling. The work will be performed at the Laboratory of Sports and Nutrition Research at Riga Stradins University.

Why it matters

Potential benefit: If successful, the results could identify specific exercise intensities that trigger anti‑cancer biological signals and help tailor post‑treatment exercise programs for survivors.

How similar studies have gone: Preclinical studies and early human translational work suggest exercise‑induced myokines can influence cancer cell biology, but direct human-to‑cell‑line data after acute exercise are limited and this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (intervention group):

* Reproductive age (premenopausal);
* Diagnosis of Stage II-III Triple-Negative Breast Cancer (TNBC) (negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2));
* Timeframe of 3 to 9 months after completion of surgery, adjuvant chemotherapy, radiation therapy, and/or immunotherapy;
* Physician-certified (cardiologist) physical fitness for exercise testing, supported by echocardiography (ECHO).

Inclusion Criteria (control group):

* Reproductive age (premenopausal);
* No current or prior diagnosis of any type of cancer;
* Matched by age, body constitution, and physical fitness to the breast cancer participant group.

Exclusion Criteria:

* Pregnancy;
* Autoimmune diseases (e.g., thyroiditis, inflammatory bowel disease, atopic dermatitis, etc.);
* Endocrine disorders (e.g., metabolic syndrome, diabetes);
* Cardiovascular diseases;
* Diagnosis of any other type of oncological disease;
* Any condition for which physical activity is contraindicated (e.g., asthma, COPD, spinal disc herniation, severe iron deficiency anemia).

Where it's running

  • Laboratory of Sports and Nutrition Research
    Riga, Dzirciema Street 16, Latvia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.